These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6600215)

  • 21. Heterologous antisera to Lyt-1+, 2- -derived antigen-binding factor detect a subfactor of an antigen-specific suppressor factor and cell surface proteins on Lyt-1+, 2- and Lyt-1-, 2+ T cells.
    Cone RE; Rosenstein RW; Tite J; Ptak W; Gershon RK
    J Immunol; 1983 May; 130(5):2083-7. PubMed ID: 6187836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of T cell-mediated cytolysis by monoclonal antibodies directed against Lyt-2: heterogeneity of inhibition at the clonal level.
    MacDonald HR; Thiernesse N; Cerottini JC
    J Immunol; 1981 May; 126(5):1671-5. PubMed ID: 6452474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of long-term cell lines and lymphoid clones reactive against murine and human tumors: a new approach to the adoptive immunotherapy of cancer.
    Rosenberg SA; Eberlein TJ; Grimm EA; Lotze MT; Mazumder A; Rosenstein M
    Surgery; 1982 Aug; 92(2):328-36. PubMed ID: 6980492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and functional characterization of IL-2 responsive T cell clones from NZB x NZW F1 mice.
    Ofosu-Appiah W; Aiello V; Sfeir G; Viti D
    J Autoimmun; 1996 Oct; 9(5):617-27. PubMed ID: 8933277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.
    Eberlein TJ; Rosenstein M; Spiess PJ; Rosenberg SA
    J Natl Cancer Inst; 1982 Jul; 69(1):109-16. PubMed ID: 6980314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro propagation and cloning of murine natural suppressor (NS) cells.
    Hertel-Wulff B; Okada S; Oseroff A; Strober S
    J Immunol; 1984 Nov; 133(5):2791-6. PubMed ID: 6237156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated isolation of unique Qa2+ Ia+ clonally derived cell lines from Qa2- mice.
    Rosenson RS; Flaherty L; Levine H; Reinisch CL
    J Immunol; 1982 Jul; 129(1):382-7. PubMed ID: 6979571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection.
    Nakayama E; Uenaka A
    J Exp Med; 1985 Feb; 161(2):345-55. PubMed ID: 3871834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rejection of syngeneic tumor cells by the interaction of Lyt-1+ T lymphocytes and macrophages.
    Mitani M; Matsumoto T; Mori K; Miake S; Himeno K; Nomoto K
    J Clin Lab Immunol; 1985 Oct; 18(2):97-101. PubMed ID: 3935795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-reactivity of anti-CD3/IL-2 activated effector cells derived from lymph nodes draining heterologous clones of a murine tumor.
    Matsumura T; Krinock RA; Chang AE; Shu S
    Cancer Res; 1993 Sep; 53(18):4315-21. PubMed ID: 8364926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
    Buessow SC; Paul RD; Lopez DM
    J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of alloantigens LY-5 and LY-6 on cytotoxic effector cells.
    Woody JN; Feldmann M; Beverley PC; McKenzie IF
    J Immunol; 1977 May; 118(5):1739-43. PubMed ID: 323358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine T-cell clones against Entamoeba histolytica: in vivo and in vitro characterization.
    Denis M; Chadee K
    Immunology; 1989 Jan; 66(1):76-82. PubMed ID: 15493266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of TL+ thymocytes with different Lyt phenotypes.
    Kisielow P; Dráber P; Wysocka M
    Eur J Immunol; 1979 Dec; 9(12):1023-5. PubMed ID: 317705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
    Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
    J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes.
    Matsumura T; Sussman JJ; Krinock RA; Chang AE; Shu S
    Cancer Res; 1994 May; 54(10):2744-50. PubMed ID: 8168105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera.
    Nakayama E; Shiku H; Stockert E; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1977-81. PubMed ID: 88050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of IL-2-dependent cytotoxic T-cell clones. III. Inhibition of killing activity by monosaccharides.
    Palladino MA; Lattime EC; Pecoraro GA; Stutman O; Oettgen HF
    Cell Immunol; 1983 Mar; 76(2):286-94. PubMed ID: 6601519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones.
    Tsutsui H; Nakanishi K; Matsui K; Higashino K; Okamura H; Miyazawa Y; Kaneda K
    J Immunol; 1996 Nov; 157(9):3967-73. PubMed ID: 8892629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.